top of page
Frequently Asked Questions
For Pet Owners
For Veterinarians and Scientists
Kv9 is a treatment designed to help dogs with solid cancers by activating their own immune system to fight the disease. It is injected directly into the tumour, where it places a harmless “marker” on the cancer cells. This marker helps the immune system recognise the tumour, which is something it often struggles to do on its own.
Once the immune system can see these marked cancer cells, it begins to attack them. In the process it can also learns how to attack them elsewhere in the body. Because the process works like a personalised vaccine, it should also help prevent the same type of cancer from returning.
If enrolled in the study, your pet will receive several small injections (less than 0.2mL at each site) of a Kv9 solution directly into their tumour mass every 14 days for up to three occasions. In some instances, a fourth dose may be considered after 3 months. In addition, there will be several follow-ups over the next two years to monitor their disease progression (there will be no charge for these follow-up appointments).
No, the Kv9 treatment is provided at no cost and necessary veterinary visits during the clinical study are covered by KVS. To be eligible for the clinical study your pet must have their tumour diagnosed by your primary care veterinarian, this is at your own cost.
KVS will provide support if there are changes in your pet suspected to be caused by participating in the trial, this is often including financial support. Any changes that are not suspected to be related to the trial or have been previously agreed upon to be excluded such as pre-exisiting conditions will be the owners responsibility to seek veterinary advice and manage.
bottom of page